The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of PDGFR-β activation as a potential bypass resistance pathway in a rhabdomyosarcoma (RMS) model of acquired resistance to IGF-1 receptor blockade.
Christine Heske
No relevant relationships to disclose
Choh Yeung
No relevant relationships to disclose
Liang Cao
No relevant relationships to disclose
Xiaolin Wan
No relevant relationships to disclose
Lee J. Helman
No relevant relationships to disclose